Thiabendazole, Dexamethasone, Neomycin Sulfate Solution

13 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

2310.0%

Death Rate

Active Ingredients

Thiabendazole, Dexamethasone, Neomycin Sulfate Solution

Administration Routes

Auricular (Otic)TopicalUnknownOral

Species Affected

Cat 9

Dog 4

Most Affected Breeds

Domestic Shorthair 6

Spaniel - Cocker American 1

Terrier - Rat 1

Siamese 1

American Shorthair 1

Shepherd Dog - Australian 1

Domestic Mediumhair 1

Great Pyrenees 1

Most Reported Reactions

Behavioural disorder NOS 3

Agitation 3

Application site alopecia 3

Application site pruritus 3

Panting 2

Pruritus 2

Weight loss 2

Elevated alanine aminotransferase (ALT) 2

Other abnormal test result NOS 2

Abnormal radiograph finding 2

Lethargy (see also Central nervous system depression in 'Neurological') 2

Dilated pupils 2

Outcome Breakdown

Recovered/Normal

6 (46.2%)

Outcome Unknown

4 (30.8%)

Died

3 (23.1%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.